Thermo Fisher Scientific Inc (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,009,000 | 8,077,000 | 8,524,000 | 4,477,000 | 10,325,000 |
| Marketable Securities | 1,561,000 | 3,000 | N/A | N/A | N/A |
| Receivables | 8,191,000 | 8,221,000 | 8,115,000 | 7,977,000 | 5,741,000 |
| Inventories | 4,978,000 | 5,088,000 | 5,634,000 | 5,051,000 | 4,029,000 |
| Other current assets | 3,398,000 | 3,200,000 | 2,956,000 | 2,608,000 | 1,862,000 |
| TOTAL | $22,137,000 | $24,589,000 | $25,229,000 | $20,113,000 | $21,957,000 |
| Non-Current Assets | |||||
| PPE Net | 9,306,000 | 9,448,000 | 9,280,000 | 8,333,000 | 5,912,000 |
| Intangibles | 61,386,000 | 60,690,000 | 58,638,000 | 62,037,000 | 38,726,000 |
| Other Non-Current Assets | 4,492,000 | 3,999,000 | 4,007,000 | 4,640,000 | 2,457,000 |
| TOTAL | $75,184,000 | $74,137,000 | $71,925,000 | $75,010,000 | $47,095,000 |
| Total Assets | $97,321,000 | $98,726,000 | $97,154,000 | $95,123,000 | $69,052,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,079,000 | 2,872,000 | 3,381,000 | 2,867,000 | 2,175,000 |
| Accrued Expenses | 1,988,000 | 1,596,000 | 2,095,000 | 2,427,000 | 1,916,000 |
| Other current liabilities | 2,852,000 | 2,689,000 | 2,601,000 | 2,655,000 | 1,271,000 |
| TOTAL | $13,332,000 | $14,012,000 | $17,010,000 | $13,436,000 | $10,304,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,061,000 | 31,308,000 | 28,909,000 | 32,333,000 | 19,107,000 |
| Other Non-Current Liabilities | 4,106,000 | 4,800,000 | 4,344,000 | 4,659,000 | 3,328,000 |
| TOTAL | $34,438,000 | $37,990,000 | $36,112,000 | $40,832,000 | $24,231,000 |
| Total Liabilities | $47,770,000 | $52,002,000 | $53,122,000 | $54,268,000 | $34,535,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 377,261 | 381,312 | 385,430 | 391,192 | 393,793 |
| Common Shares | 444,000 | 442,000 | 441,000 | 439,000 | 437,000 |
| Retained earnings | 53,102,000 | 47,364,000 | 41,910,000 | 35,431,000 | 28,116,000 |
| Other shareholders' equity | -2,731,000 | -3,235,000 | -3,045,000 | -2,267,000 | -2,797,000 |
| TOTAL | $49,551,000 | $46,724,000 | $44,032,000 | $40,855,000 | $34,517,000 |
| Total Liabilities And Equity | $97,321,000 | $98,726,000 | $97,154,000 | $95,123,000 | $69,052,000 |